Three Remain Liable On UK Liothyronine Price Abuse – But Fines Slimmed On Appeal

Advanz Pharma Loses Both Liability And Fine Appeals, Deemed ‘Unimpeachable’

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".